Velcade for Proliferative Lupus Nephritis
| Status: | Archived |
|---|---|
| Conditions: | Lupus, Endocrine, Nephrology, Urology |
| Therapuetic Areas: | Endocrinology, Immunology / Infectious Diseases, Nephrology / Urology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | August 2010 |
| End Date: | December 2011 |
The primary objective is to test the safety and efficacy of Velcade to induce remission in
WHO class III/IV/V lupus nephritis that are refractory to standard medications.
This exploratory single center, open-label, single treatment group assignment, safety, and
efficacy study will enroll 14 patients with WHO class III/IV/V lupus nephritis. Subjects
will receive 12 doses of Velcade to induce clinical remission.
We found this trial at
1
site
Click here to add this to my saved trials
